Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users ...

Plaintiffs said the companies knew, or should have known, that ranitidine posed a cancer risk and that they failed to warn consumers. The U.S. Food and Drug Administration asked manufacturers to ...

Sanofi said it reached an agreement in principle to settle about 4,000 claims around allegations that its heartburn drug Zantac caused cancer. The company said in a statement on Wednesday that the ...

Animal studies have shown that NDMA can increase the risk ... the the drug, which she had been using since 2005, was responsible for her esophageal cancer. Ms Haskins said that ranitidine's ...

Zantac, developed by GSK and Warner-Lambert, hit the US market as a prescription drug in 1983 before becoming an over-the-counter heartburn treatment in 1996. It was owned by several companies ...

Sanofi will pay more than US$100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn ...

Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug ... that ranitidine posed a cancer risk and that they failed to warn ...